Cancer Research in Switzerland - Krebsliga Schweiz
Cancer Research in Switzerland - Krebsliga Schweiz
Cancer Research in Switzerland - Krebsliga Schweiz
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
eport long-term impairment of sense of well-be<strong>in</strong>g, reflected<br />
by low levels of health-related quality of life<br />
(HRQoL) and high levels of depression and anxiety. Very<br />
little effort has been expended <strong>in</strong> exam<strong>in</strong><strong>in</strong>g whether<br />
behavioural <strong>in</strong>terventions can serve to improve dist<strong>in</strong>ct<br />
parameters of well-be<strong>in</strong>g, e. g. HRQoL, depression, fatigue<br />
and anxiety.<br />
Aim<br />
M<strong>in</strong>dfulness-based <strong>in</strong>tervention (MBI) is a group behavioural<br />
program aimed at improv<strong>in</strong>g aspects of well-be<strong>in</strong>g<br />
for patients with a broad spectrum of chronic disorders<br />
(detailed description provided later). The primary goal of<br />
this <strong>in</strong>vestigation is to exam<strong>in</strong>e whether MBI is a feasible<br />
and effective <strong>in</strong>tervention for HSCT survivors <strong>in</strong> terms of<br />
enhanc<strong>in</strong>g different dimensions of HRQoL (e. g. psychological<br />
function<strong>in</strong>g, positive emotions, social contact and<br />
ability to enjoy life) and decreas<strong>in</strong>g depression, fatigue<br />
and anxiety.<br />
Methods<br />
Us<strong>in</strong>g a controlled patient-preference procedure, MBI is<br />
compared to a comparison <strong>in</strong>tervention of augmented optimal<br />
medical care, where patients, additional to usual<br />
medical care, receive brief telephone medical and psychosocial<br />
consultations twice a month dur<strong>in</strong>g the <strong>in</strong>tervention<br />
phase. Feasibility of <strong>in</strong>terventions will be evaluated by<br />
measur<strong>in</strong>g aspects of acceptability of <strong>in</strong>terventions (percentage<br />
of <strong>in</strong>vited patients who participate, the dropout<br />
rate for the program, the average weekly attendance rate<br />
and the degree to which patients perceive that their personal<br />
goals for the <strong>in</strong>tervention have been met). Efficacy<br />
of treatment will be evaluated by validated <strong>in</strong>ventories of<br />
HRQoL, depression and fatigue as primary outcomes.<br />
Anxiety, personal growth and physical health status will<br />
be employed as secondary measures. We plan to <strong>in</strong>clude<br />
100 patients <strong>in</strong> the study and to exam<strong>in</strong>e benefits directly<br />
after the <strong>in</strong>tervention period and at 3 months follow-up.<br />
Results<br />
This study is ongo<strong>in</strong>g, and 51 patients are thus far participat<strong>in</strong>g.<br />
Few patients dropped out of the study before<br />
complet<strong>in</strong>g the <strong>in</strong>tervention (